Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With18 F-Fluorodeoxyglucose-Positron Emission Tomography Imaging

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2014, Vol.63 (1), p.86-88
Main Authors: Tawakol, Ahmed, MD, Singh, Parmanand, MD, Rudd, James H.F., PhD, Soffer, Joseph, MD, Cai, Gengqian, PhD, Vucic, Esad, MD, Brannan, Sarah P., DPhil, Tarka, Elizabeth A., MD, Shaddinger, Bonnie C., PharmD, Sarov-Blat, Lea, PhD, Matthews, Paul, MD, Subramanian, Sharath, MD, Farkouh, Michael, MD, Fayad, Zahi A., PhD
Format: Article
Language:English
Subjects:
Cardiovascular
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0735-1097
DOI:10.1016/j.jacc.2013.07.050